26 Jun 2018

FLYING HIGH OVER THE SEA OF SAMENESS: WHAT IS THE ROLE OF CONFORMITY IN VEIN TREATMENT?

  By James R. Williams   Healthcare bleeds conformity. And for the most part, for good reason. Physicians are trained to rely on statistically proven techniques to treat a condition. These techniques become the gold standard. Physicians are taught not to deviate from these standards until empirical evidence of another

0
26 Jun 2018

THE MARKETING BOT: HOW TO USE YOUR TIRELESS, HIGH-ROI MARKETING GENIUS

By Scott Harvey It’s been said, and it’s pretty well-accepted, that e-mail is the “killer app” that turned the Internet from an interesting technology into the behemoth it has become. There’s no question that email, and its offspring such as various messaging apps such as Facebook Messenger and WhatsApp, have

0
26 Jun 2018

VENA CAVA FILTERS TO SEE DOUBLE-DIGIT CAGR ANNUAL GROWTH

The global inferior vena cava filters (IVCFs)market is expected to grow at a compounded annual growth rate (CAGR) of more than 11 percent during the period 2018-2022, according to a new 126-page market research study (SKU: IRTNTR21662) published early this year by Technavio. A free sample report or the full

0
24 Jun 2018

INTACT VASCULAR OFFERS TOBA BTK DATA

Intact Vascular Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, has praised the publication of the Tack Optimized Balloon Angioplasty Below the Knee (TOBA BTK) clinical trial results in the current issue of Catheterization and Cardiovascular Intervention. This multi-center pilot study focused on collecting data supporting

0
24 Jun 2018

AMERICAN VEIN AIDS HEALTH4HAITI BY DONATING 50 SETS OF SCRUBS

American Vein & Vascular Institute recently donated more than 50 sets of scrubs to Health4Haiti, a non-profit that improves lives and healthcare outcomes for the citizens of Gonaives, Haiti. Gonaives is currently served by one public hospital, according to Health4Haiti’s website (healthfourhaiti.com), and that hospital has been destroyed twice due

0
21 Jun 2018

MOST VENOUS DISEASE CAN BE CLASSIFIED AS COSMETIC

      By Ronald Bush, MD, FACS In 1992, I left a busy practice of thoracic and vascular surgery and began the in-office treatment of varicose veins. At that time, high ligation and stripping using tumescent with ultra sound guided assistance was our treatment of choice for saphenous insufficiency.

0
13 Jun 2018

CASE STUDY: MANAGING PERSISTENT SWELLING AFTER ENDOVENOUS ABLATION

  By Tim Crawlield I have practiced phleboloby for six years and I learned early in my career that patients with swelling in the lower extremities — swelling that cannot be contained by elastic graduated compression stockings — do not benefit from endovenous ablations. My general rule of thumb is

0
13 Jun 2018

2018 RESEARCH SUMMIT: WORK BEGINS TO ANALYZE DATA IN RAPIDLY EXPANDING ACP PRO VENOUS REGISTRY

By Vanessa Salvia Contributing Editor Anticipation was high for many members of the phlebology community going into an April 21 closed-door research summit held alongside the International Vein Congress in Miami, convened to discuss how to make the most of the American College of Phlebology’s Patient Recorded Outcome Venous Registry,

0
07 Jun 2018

OPTALYSE PE: BTG RESULTS REINFORCE SAFETY, EFFICACY OF SHORTER, LOWER DOSE EKOS THERAPY FOR PE

BTG plc highlighted OPTALYSE PE one-year trial results, presented at the International Society on Endovascular Therapy in Florida in February. The findings confirm that bilateral pulmonary embolism (PE) patients treated in as little as two hours with a total tissue plasminogen activator (tPA) dose as low as 8mg continue to

0
29 May 2018

INTACT VASCULAR SPONSORS SYMPOSIUM ON POST-ANGIOPLASTY DISSECTIONS MAY 31

Intact Vascular Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, announced May 29 the schedule of key presentations that will be featured during a symposium sponsored together with Philips at the 19th Annual New Cardiovascular Horizons (NCVH) Conference  in New Orleans on May 31. Post-Percutaneous Transluminal Angioplasty (“PTA”)

0